Results 161 to 170 of about 24,763,168 (195)

Preventing Allergic Reactions to Gadolinium-Based Contrast Agents

Topics in Magnetic Resonance Imaging, 2016
Although the low incidence of immediate-type gadolinium-based contrast agent (GBCA) allergic reactions is widely known, preventing these reactions and properly managing them to reduce their adverse sequel can improve the already exceedingly favorable GBCA safety profile.
Ashkan, Heshmatzadeh Behzadi, Martin R, Prince   +1 more
openaire   +2 more sources

Chapter 2. Gadolinium-based Contrast Agents

2017
In this chapter, the development of efficient GdIII-based agents for MRI is detailed. This chapter is divided into ten sections covering the general theory of the relaxivity of GdIII-based contrast agents; the measurement of longitudinal (T1) and transverse (T2) relaxation times; the theory, acquisition, and interpretation of NMRD profiles; the ...
L. Helm, J. R. Morrow, C. J. Bond, F. Carniato, M. Botta, M. Braun, Z. Baranyai, R. Pujales-Paradela, M. Regueiro-Figueroa, D. Esteban-Gómez, C. Platas-Iglesias, T. J. Scholl   +11 more
openaire   +3 more sources

Gadolinium-based contrast agents in angiography and interventional radiology

Radiologic Clinics of North America, 2002
Gadolinium is useful as an alternative contrast agent for diagnostic angiographic and interventional procedures in patients with renal insufficiency or a history of a severe reaction to iodinated contrast material. Gadolinium usually is used as a "problem solver" to answer specific diagnostic questions or guide interventional procedures that cannot ...
David J, Spinosa, J Fritz, Angle, Gary D, Hartwell, Klaus D, Hagspiel, Daniel A, Leung, Alan H, Matsumoto   +5 more
openaire   +2 more sources

Gadolinium‐based contrast agents: A comprehensive risk assessment

Journal of Magnetic Resonance Imaging, 2017
Gadolinium‐based contrast agents (GBCAs) have been used in magnetic resonance imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI examinations. While GBCAs were initially felt to carry minimal risk, the subsequent identification of GBCAs as the key etiologic factor in the development of nephrogenic systemic fibrosis (NSF) has
Tyler J, Fraum, Daniel R, Ludwig, Mustafa R, Bashir, Kathryn J, Fowler   +3 more
openaire   +2 more sources

Gadolinium-Based Contrast Agent

2018
GBCA ...
openaire   +2 more sources

Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents

Advances in Chronic Kidney Disease, 2011
The strong association between nephrogenic systemic fibrosis (NSF) and exposure to gadolinium-based contrast agents (GBCAs) has greatly affected the care of patients with kidney disease. NSF has been reported in patients with ESRD, CKD, and acute kidney injury (AKI).
openaire   +2 more sources

Effects of gadolinium‐based MRI contrast agents on liver tissue

Journal of Magnetic Resonance Imaging, 2018
BackgroundMRI with contrast is often used clinically. However, recent studies have reported a high accumulation of gadolinium‐based contrast agents (GBCAs) in kidney, liver, and spleen tissues in several mouse models.PurposeTo compare the effects on liver tissue of gadolinium‐based MRI contrast agents in the light of biochemical and histopathological ...
Tolga Mercantepe, Levent Tümkaya, Fatma Beyazal Çeliker, Zehra Topal Suzan, Seda Çinar, Kerimali Akyildiz, Filiz Mercantepe, Adnan Yilmaz   +7 more
openaire   +3 more sources

Gadolinium-Based Contrast Agents

2023
Menhel Kinno, Joanne Sutter
openaire   +1 more source

Strategies for Increasing the Sensitivity of Gadolinium Based MRI Contrast Agents

ChemInform, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
openaire   +2 more sources

Lifecycle of Gadolinium‐Based Contrast Agents

Journal of Magnetic Resonance Imaging, 2020
openaire   +2 more sources